Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 751 entries
Sorted by: Best Match Show Resources per page
“No significant distance” between face-to-face and online instruction: Evidence from principles of economics

technology education

Coates D, Humphreys BR, Kane J.
GSID: iuYUAYfGHRUJ
D Coates, BR Humphreys, J Kane… - Economics of Education …, 2004 - Elsevier

This paper describes an experiment focused on measuring and explaining differences in students learning between online and face-to-face modes of instruction in college level …

Cite
Coates, D., Humphreys, B. R., Kane, J., & Vachris, M. A. (2004). “No significant distance” between face-to-face and online instruction: Evidence from principles of economics. Economics of Education Review, 23(5), 533-546.
Coates, Dennis, et al. "“No significant distance” between face-to-face and online instruction: Evidence from principles of economics." Economics of Education Review 23.5 (2004): 533-546.
Copy Download .nbib Format: MLA
Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy.

Frontiers in aging neuroscience

Lyons BE, Austin D, Seelye A, Petersen J, Yeargers J, Riley T, Sharma N, Mattek N, Dodge H, Wild K, Kaye JA.
PMID: 26696884
Front Aging Neurosci. 2015 Dec 11;7:232. doi: 10.3389/fnagi.2015.00232. eCollection 2015.

[This corrects the article on p. 102 in vol. 7, PMID: 26113819.].

Cite
Lyons BE, Austin D, Seelye A, et al. Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Front Aging Neurosci. 2015;7:232doi: 10.3389/fnagi.2015.00232.
Lyons, B. E., Austin, D., Seelye, A., Petersen, J., Yeargers, J., Riley, T., Sharma, N., Mattek, N., Dodge, H., Wild, K., & Kaye, J. A. (2015). Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Frontiers in aging neuroscience, 7232. https://doi.org/10.3389/fnagi.2015.00232
Lyons, Bayard E, et al. "Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy." Frontiers in aging neuroscience vol. 7 (2015): 232. doi: https://doi.org/10.3389/fnagi.2015.00232
Lyons BE, Austin D, Seelye A, Petersen J, Yeargers J, Riley T, Sharma N, Mattek N, Dodge H, Wild K, Kaye JA. Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Front Aging Neurosci. 2015 Dec 11;7:232. doi: 10.3389/fnagi.2015.00232. eCollection 2015. PMID: 26696884; PMCID: PMC4675995.
Copy Download .nbib Format: NLM
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib.

Advances in hematology

Davis KL, Côté I, Kaye JA, Mendelson E, Gao H, Perez Ronco J.
PMID: 26635878
Adv Hematol. 2015;2015:848473. doi: 10.1155/2015/848473. Epub 2015 Nov 09.

Few trial-based assessments of ruxolitinib in patients with lower-risk myelofibrosis (MF) have been conducted, and no studies have made such assessments in a real-world population. We assessed changes in spleen size and constitutional symptoms during ruxolitinib treatment using a...

Cite
Davis KL, Côté I, Kaye JA, et al. Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib. Adv Hematol. 2015;2015:848473doi: 10.1155/2015/848473.
Davis, K. L., Côté, I., Kaye, J. A., Mendelson, E., Gao, H., & Perez Ronco, J. (2015). Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib. Advances in hematology, 2015848473. https://doi.org/10.1155/2015/848473
Davis, Keith L, et al. "Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib." Advances in hematology vol. 2015 (2015): 848473. doi: https://doi.org/10.1155/2015/848473
Davis KL, Côté I, Kaye JA, Mendelson E, Gao H, Perez Ronco J. Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib. Adv Hematol. 2015;2015:848473. doi: 10.1155/2015/848473. Epub 2015 Nov 09. PMID: 26635878; PMCID: PMC4655278.
Copy Download .nbib Format: NLM
Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

Experimental hematology & oncology

Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S.
PMID: 29152412
Exp Hematol Oncol. 2017 Nov 09;6:30. doi: 10.1186/s40164-017-0090-5. eCollection 2017.

BACKGROUND: Pegylated interferon alfa-2a (PEG-IFN-α-2a) is a potent immunomodulating agent capable of inducing high rate of hematologic and even complete molecular remission in patients with essential thrombocythemia (ET) and polycythemia vera (PV). We recently reported results of a phase...

Cite
Masarova L, Yin CC, Cortes JE, et al. Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol. 2017;6:30doi: 10.1186/s40164-017-0090-5.
Masarova, L., Yin, C. C., Cortes, J. E., Konopleva, M., Borthakur, G., Newberry, K. J., Kantarjian, H. M., Bueso-Ramos, C. E., & Verstovsek, S. (2017). Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Experimental hematology & oncology, 630. https://doi.org/10.1186/s40164-017-0090-5
Masarova, Lucia, et al. "Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)." Experimental hematology & oncology vol. 6 (2017): 30. doi: https://doi.org/10.1186/s40164-017-0090-5
Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol. 2017 Nov 09;6:30. doi: 10.1186/s40164-017-0090-5. eCollection 2017. PMID: 29152412; PMCID: PMC5679503.
Copy Download .nbib Format: NLM
MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells.

American journal of cancer research

Khodayari N, Mohammed KA, Lee H, Kaye F, Nasreen N.
PMID: 27725905
Am J Cancer Res. 2016 Sep 01;6(9):1996-2009. eCollection 2016.

MicroRNAs belonging to the miR-302 family are emerging as key players in the control of cell growth, and maintaining pluripotency during cell fate determination and differentiation in embryonic stem cells. However, the mechanisms whereby ephA2/ephirnA1 signaling regulates miR-302b expression...

Cite
Khodayari N, Mohammed KA, Lee H, et al. MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. Am J Cancer Res. 2016;6(9):1996-2009
Khodayari, N., Mohammed, K. A., Lee, H., Kaye, F., & Nasreen, N. (2016). MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. American journal of cancer research, 6(9), 1996-2009.
Khodayari, Nazli, et al. "MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells." American journal of cancer research vol. 6,9 (2016): 1996-2009.
Khodayari N, Mohammed KA, Lee H, Kaye F, Nasreen N. MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. Am J Cancer Res. 2016 Sep 01;6(9):1996-2009. eCollection 2016. PMID: 27725905; PMCID: PMC5043109.
Copy Download .nbib Format: NLM
The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)

Burfeind KG, Murchison CF, Westaway SK, Simon MJ, Erten-Lyons D, Kaye JA, Quinn JF, Iliff JJ.
PMID: 29067342
Alzheimers Dement (N Y). 2017 May 26;3(3):348-359. doi: 10.1016/j.trci.2017.05.001. eCollection 2017 Sep.

INTRODUCTION: The glymphatic system is a brain-wide perivascular network that facilitates clearance of proteins, including amyloid β, from the brain interstitium through the perivascular exchange of cerebrospinal fluid and interstitial fluid. The astrocytic water channel aquaporin-4 (AQP4) is required...

Cite
Burfeind KG, Murchison CF, Westaway SK, et al. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease. Alzheimers Dement (N Y). 2017;3(3):348-359doi: 10.1016/j.trci.2017.05.001.
Burfeind, K. G., Murchison, C. F., Westaway, S. K., Simon, M. J., Erten-Lyons, D., Kaye, J. A., Quinn, J. F., & Iliff, J. J. (2017). The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 3(3), 348-359. https://doi.org/10.1016/j.trci.2017.05.001
Burfeind, Kevin G, et al. "The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease." Alzheimer's & dementia (New York, N. Y.) vol. 3,3 (2017): 348-359. doi: https://doi.org/10.1016/j.trci.2017.05.001
Burfeind KG, Murchison CF, Westaway SK, Simon MJ, Erten-Lyons D, Kaye JA, Quinn JF, Iliff JJ. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease. Alzheimers Dement (N Y). 2017 May 26;3(3):348-359. doi: 10.1016/j.trci.2017.05.001. eCollection 2017 Sep. PMID: 29067342; PMCID: PMC5651426.
Copy Download .nbib Format: NLM
Time and Life Management for Medical Students and Residents.

Plastic and reconstructive surgery

Buretta KJ.
PMID: 29068950
Plast Reconstr Surg. 2017 Nov;140(5):1078. doi: 10.1097/PRS.0000000000003823.

No abstract available.

Cite
Buretta KJ. Time and Life Management for Medical Students and Residents. Plast Reconstr Surg. 2017;140(5):1078doi: 10.1097/PRS.0000000000003823.
Buretta, K. J. (2017). Time and Life Management for Medical Students and Residents. Plastic and reconstructive surgery, 140(5), 1078. https://doi.org/10.1097/PRS.0000000000003823
Buretta, Kate J. "Time and Life Management for Medical Students and Residents." Plastic and reconstructive surgery vol. 140,5 (2017): 1078. doi: https://doi.org/10.1097/PRS.0000000000003823
Buretta KJ. Time and Life Management for Medical Students and Residents. Plast Reconstr Surg. 2017 Nov;140(5):1078. doi: 10.1097/PRS.0000000000003823. PMID: 29068950.
Copy Download .nbib Format: NLM
Effective Tobacco Cessation via Health Coaching: An Institutional Case Report.

Global advances in health and medicine

Sforzo GA, Kaye M, Ayers GD, Talbert B, Hill M.
PMID: 25568823
Glob Adv Health Med. 2014 Sep;3(5):37-44. doi: 10.7453/gahmj.2014.029.

BACKGROUND: Tobacco abuse is a well-recognized scourge on health and healthcare costs. Attempts to facilitate tobacco cessation are rarely better than marginally effective.PRIMARY OBJECTIVE: To describe an observational trial of an existing and highly successful tobacco cessation program featuring...

Cite
Sforzo GA, Kaye M, Ayers GD, et al. Effective Tobacco Cessation via Health Coaching: An Institutional Case Report. Glob Adv Health Med. 2014;3(5):37-44doi: 10.7453/gahmj.2014.029.
Sforzo, G. A., Kaye, M., Ayers, G. D., Talbert, B., & Hill, M. (2014). Effective Tobacco Cessation via Health Coaching: An Institutional Case Report. Global advances in health and medicine, 3(5), 37-44. https://doi.org/10.7453/gahmj.2014.029
Sforzo, Gary A, et al. "Effective Tobacco Cessation via Health Coaching: An Institutional Case Report." Global advances in health and medicine vol. 3,5 (2014): 37-44. doi: https://doi.org/10.7453/gahmj.2014.029
Sforzo GA, Kaye M, Ayers GD, Talbert B, Hill M. Effective Tobacco Cessation via Health Coaching: An Institutional Case Report. Glob Adv Health Med. 2014 Sep;3(5):37-44. doi: 10.7453/gahmj.2014.029. PMID: 25568823; PMCID: PMC4268607.
Copy Download .nbib Format: NLM
The effect of performing a dual task on postural control in children with autism.

ISRN neuroscience

Bucci MP, Doyen C, Contenjean Y, Kaye K.
PMID: 24959567
ISRN Neurosci. 2013 Oct 30;2013:796174. doi: 10.1155/2013/796174. eCollection 2013.

The aim of the study was to explore the effect of eye movements (saccades and pursuits) on postural stability in children with autism versus typically developing children of comparable age. Postural stability was recorded with a platform (Techno Concept)...

Cite
Bucci MP, Doyen C, Contenjean Y, et al. The effect of performing a dual task on postural control in children with autism. ISRN Neurosci. 2013;2013:796174doi: 10.1155/2013/796174.
Bucci, M. P., Doyen, C., Contenjean, Y., & Kaye, K. (2013). The effect of performing a dual task on postural control in children with autism. ISRN neuroscience, 2013796174. https://doi.org/10.1155/2013/796174
Bucci, Maria Pia, et al. "The effect of performing a dual task on postural control in children with autism." ISRN neuroscience vol. 2013 (2013): 796174. doi: https://doi.org/10.1155/2013/796174
Bucci MP, Doyen C, Contenjean Y, Kaye K. The effect of performing a dual task on postural control in children with autism. ISRN Neurosci. 2013 Oct 30;2013:796174. doi: 10.1155/2013/796174. eCollection 2013. PMID: 24959567; PMCID: PMC4045564.
Copy Download .nbib Format: NLM
Whole genome investigation of a divergent clade of the pathogen Streptococcus suis.

Frontiers in microbiology

Baig A, Weinert LA, Peters SE, Howell KJ, Chaudhuri RR, Wang J, Holden MT, Parkhill J, Langford PR, Rycroft AN, Wren BW, Tucker AW, Maskell DJ.
PMID: 26583006
Front Microbiol. 2015 Nov 04;6:1191. doi: 10.3389/fmicb.2015.01191. eCollection 2015.

Streptococcus suis is a major porcine and zoonotic pathogen responsible for significant economic losses in the pig industry and an increasing number of human cases. Multiple isolates of S. suis show marked genomic diversity. Here, we report the analysis...

Cite
Baig A, Weinert LA, Peters SE, et al. Whole genome investigation of a divergent clade of the pathogen Streptococcus suis. Front Microbiol. 2015;6:1191doi: 10.3389/fmicb.2015.01191.
Baig, A., Weinert, L. A., Peters, S. E., Howell, K. J., Chaudhuri, R. R., Wang, J., Holden, M. T., Parkhill, J., Langford, P. R., Rycroft, A. N., Wren, B. W., Tucker, A. W., & Maskell, D. J. (2015). Whole genome investigation of a divergent clade of the pathogen Streptococcus suis. Frontiers in microbiology, 61191. https://doi.org/10.3389/fmicb.2015.01191
Baig, Abiyad, et al. "Whole genome investigation of a divergent clade of the pathogen Streptococcus suis." Frontiers in microbiology vol. 6 (2015): 1191. doi: https://doi.org/10.3389/fmicb.2015.01191
Baig A, Weinert LA, Peters SE, Howell KJ, Chaudhuri RR, Wang J, Holden MT, Parkhill J, Langford PR, Rycroft AN, Wren BW, Tucker AW, Maskell DJ. Whole genome investigation of a divergent clade of the pathogen Streptococcus suis. Front Microbiol. 2015 Nov 04;6:1191. doi: 10.3389/fmicb.2015.01191. eCollection 2015. PMID: 26583006; PMCID: PMC4631834.
Copy Download .nbib Format: NLM
Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.

Metabolomics : Official journal of the Metabolomic Society

Leichtle AB, Ceglarek U, Weinert P, Nakas CT, Nuoffer JM, Kase J, Conrad T, Witzigmann H, Thiery J, Fiedler GM.
PMID: 23678345
Metabolomics. 2013 Jun;9(3):677-687. doi: 10.1007/s11306-012-0476-7. Epub 2012 Nov 06.

Metabolomics as one of the most rapidly growing technologies in the "-omics" field denotes the comprehensive analysis of low molecular-weight compounds and their pathways. Cancer-specific alterations of the metabolome can be detected by high-throughput mass-spectrometric metabolite profiling and serve...

Cite
Leichtle AB, Ceglarek U, Weinert P, et al. Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma. Metabolomics. 2012;9(3):677-687doi: 10.1007/s11306-012-0476-7.
Leichtle, A. B., Ceglarek, U., Weinert, P., Nakas, C. T., Nuoffer, J. M., Kase, J., Conrad, T., Witzigmann, H., Thiery, J., & Fiedler, G. M. (2013). Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma. Metabolomics : Official journal of the Metabolomic Society, 9(3), 677-687. https://doi.org/10.1007/s11306-012-0476-7
Leichtle, Alexander Benedikt, et al. "Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma." Metabolomics : Official journal of the Metabolomic Society vol. 9,3 (2013): 677-687. doi: https://doi.org/10.1007/s11306-012-0476-7
Leichtle AB, Ceglarek U, Weinert P, Nakas CT, Nuoffer JM, Kase J, Conrad T, Witzigmann H, Thiery J, Fiedler GM. Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma. Metabolomics. 2013 Jun;9(3):677-687. doi: 10.1007/s11306-012-0476-7. Epub 2012 Nov 06. PMID: 23678345; PMCID: PMC3651533.
Copy Download .nbib Format: NLM
Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours.

Nature communications

Chae YC, Angelin A, Lisanti S, Kossenkov AV, Speicher KD, Wang H, Powers JF, Tischler AS, Pacak K, Fliedner S, Michalek RD, Karoly ED, Wallace DC, Languino LR, Speicher DW, Altieri DC.
PMID: 26085380
Nat Commun. 2015 Jun 18;6:7605. doi: 10.1038/ncomms8605.

No abstract available.

Cite
Chae YC, Angelin A, Lisanti S, et al. Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun. 2015;6:7605doi: 10.1038/ncomms8605.
Chae, Y. C., Angelin, A., Lisanti, S., Kossenkov, A. V., Speicher, K. D., Wang, H., Powers, J. F., Tischler, A. S., Pacak, K., Fliedner, S., Michalek, R. D., Karoly, E. D., Wallace, D. C., Languino, L. R., Speicher, D. W., & Altieri, D. C. (2015). Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours. Nature communications, 67605. https://doi.org/10.1038/ncomms8605
Chae, Young Chan, et al. "Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours." Nature communications vol. 6 (2015): 7605. doi: https://doi.org/10.1038/ncomms8605
Chae YC, Angelin A, Lisanti S, Kossenkov AV, Speicher KD, Wang H, Powers JF, Tischler AS, Pacak K, Fliedner S, Michalek RD, Karoly ED, Wallace DC, Languino LR, Speicher DW, Altieri DC. Corrigendum: Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun. 2015 Jun 18;6:7605. doi: 10.1038/ncomms8605. PMID: 26085380; PMCID: PMC4750482.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 751 entries